Literature DB >> 6723761

Pharmacokinetic and pharmacodynamic interaction study of diazepam and metoprolol.

U Klotz, I W Reimann.   

Abstract

In 6 normotensive, healthy male volunteers the pharmacodynamic responses (blood pressure, heart rate; sedation index, tracking test, reaction time) to metoprolol (100 mg bid orally), diazepam (0.1 mg/kg intravenously) and to their combination were studied. The pharmacokinetics of diazepam were also compared in a cross-over experiment, with and without pretreatment by the beta-adrenoceptor antagonist to evaluate the possibility of a drug interaction. The pharmacodynamic and pharmacokinetic investigations indicated that metoprolol only slightly impaired the elimination of diazepam (18% decrease in total clearance, 25% increase in elimination half-life). The pharmacodynamics of metoprolol (17% decrease in heart rate, 17% decrease in diastolic RR) was not significantly altered by the bolus injection of diazepam. The extent of prolongation in choice reaction time (RT2) induced by diazepam was significantly (p = 0.001) more pronounced following the co-administration of metoprolol. However, the results of RT1, the tracking test and the sedation index did not indicate any increased effect due to the beta-blocking agent. It is concluded that concomitant treatment with metoprolol and diazepam causes only minor and clinically irrelevant changes in drug metabolism and drug response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723761     DOI: 10.1007/BF00630289

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Interaction of a series of beta-adrenergic blocking drugs with rat hepatic microsomal monooxygenase.

Authors:  R M Facino; R Lanzani
Journal:  Pharmacol Res Commun       Date:  1979-05

2.  Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.

Authors:  C S Deacon; M S Lennard; N D Bax; H F Woods; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

3.  Effect of propranolol on morphine metabolism.

Authors:  S F Brunk; M Delle; W R Wilson
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

4.  Effects of metoprolol and propranolol on theophylline elimination.

Authors:  K A Conrad; D W Nyman
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

5.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

6.  The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.

Authors:  T K Daneshmend; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 7.  [Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].

Authors:  U Klotz; I Reimann
Journal:  Klin Wochenschr       Date:  1983-07-01

Review 8.  Pharmacokinetic drug interactions with propranolol.

Authors:  A J Wood; J Feely
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

9.  Diazepam, propranolol and their combination in the management of chronic anxiety.

Authors:  C Hallstrom; I Treasaden; J G Edwards; M Lader
Journal:  Br J Psychiatry       Date:  1981-11       Impact factor: 9.319

10.  Impairment of antipyrine clearance in humans by propranolol.

Authors:  D J Greenblatt; K Franke; D H Huffman
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  3 in total

1.  Voriconazole and fluconazole increase the exposure to oral diazepam.

Authors:  Teijo I Saari; Kari Laine; Leif Bertilsson; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2007-08-04       Impact factor: 2.953

2.  Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.

Authors:  U Klotz; P Arvela; B Rosenkranz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 3.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.